HEADER IMMUNE SYSTEM 07-MAY-19 6RMT TITLE CRYSTAL STRUCTURE OF DISULPHIDE-LINKED HUMAN C3D DIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT C3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: C3 AND PZP-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING COMPND 5 PROTEIN 1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: FULL LENGTH HUMAN C3D SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: C3, CPAMD1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS COMPLEMENT, INNATE IMMUNITY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.A.WAHID,J.M.H.VAN DEN ELSEN,S.J.CRENNELL REVDAT 3 24-JAN-24 6RMT 1 REMARK REVDAT 2 01-DEC-21 6RMT 1 JRNL REVDAT 1 18-NOV-20 6RMT 0 JRNL AUTH A.A.WAHID,R.W.DUNPHY,A.MACPHERSON,B.G.GIBSON,L.KULIK, JRNL AUTH 2 K.WHALE,C.BACK,T.M.HALLAM,B.ALKHAWAJA,R.L.MARTIN,I.MESCHEDE, JRNL AUTH 3 M.LAABEI,A.D.G.LAWSON,V.M.HOLERS,A.G.WATTS,S.J.CRENNELL, JRNL AUTH 4 C.L.HARRIS,K.J.MARCHBANK,J.M.H.VAN DEN ELSEN JRNL TITL INSIGHTS INTO THE STRUCTURE-FUNCTION RELATIONSHIPS OF JRNL TITL 2 DIMERIC C3D FRAGMENTS. JRNL REF FRONT IMMUNOL V. 12 14055 2021 JRNL REFN ESSN 1664-3224 JRNL PMID 34434196 JRNL DOI 10.3389/FIMMU.2021.714055 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 39776 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.142 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.7077 - 4.8195 1.00 2888 161 0.1557 0.1899 REMARK 3 2 4.8195 - 3.8256 1.00 2762 153 0.1124 0.1589 REMARK 3 3 3.8256 - 3.3421 1.00 2727 142 0.1313 0.1794 REMARK 3 4 3.3421 - 3.0365 1.00 2692 145 0.1538 0.2265 REMARK 3 5 3.0365 - 2.8189 1.00 2721 140 0.1580 0.2107 REMARK 3 6 2.8189 - 2.6527 1.00 2700 130 0.1577 0.2255 REMARK 3 7 2.6527 - 2.5198 1.00 2682 140 0.1489 0.2277 REMARK 3 8 2.5198 - 2.4102 1.00 2681 123 0.1324 0.2023 REMARK 3 9 2.4102 - 2.3174 1.00 2666 132 0.1352 0.1983 REMARK 3 10 2.3174 - 2.2374 1.00 2664 156 0.1367 0.2076 REMARK 3 11 2.2374 - 2.1674 1.00 2649 149 0.1422 0.2170 REMARK 3 12 2.1674 - 2.1055 1.00 2627 163 0.1458 0.2167 REMARK 3 13 2.1055 - 2.0501 1.00 2670 138 0.1544 0.2090 REMARK 3 14 2.0501 - 2.0000 1.00 2642 133 0.1670 0.2433 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4983 REMARK 3 ANGLE : 0.948 6775 REMARK 3 CHIRALITY : 0.049 742 REMARK 3 PLANARITY : 0.007 886 REMARK 3 DIHEDRAL : 12.933 3011 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISULPHIDE BOND CRITERIA EDITED TO REMARK 3 ALLOW ONE CONFORMATION NOT TO FORM REMARK 4 REMARK 4 6RMT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1292102218. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39938 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 58.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 21.10 REMARK 200 R MERGE (I) : 0.17700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 21.10 REMARK 200 R MERGE FOR SHELL (I) : 1.00200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BALBES REMARK 200 STARTING MODEL: 2WY7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8, 200 MM NACL, 24% PEG REMARK 280 4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.31200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.74400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.94800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.74400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.31200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.94800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 302 REMARK 465 VAL A 303 REMARK 465 SER A 304 REMARK 465 LEU A 305 REMARK 465 GLN A 306 REMARK 465 LEU A 307 REMARK 465 PRO A 308 REMARK 465 SER A 309 REMARK 465 ARG A 310 REMARK 465 LEU B 299 REMARK 465 ASN B 300 REMARK 465 LEU B 301 REMARK 465 ASP B 302 REMARK 465 VAL B 303 REMARK 465 SER B 304 REMARK 465 LEU B 305 REMARK 465 GLN B 306 REMARK 465 LEU B 307 REMARK 465 PRO B 308 REMARK 465 SER B 309 REMARK 465 ARG B 310 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE21 GLN B 20 O HOH B 501 1.54 REMARK 500 OE1 GLU A 265 O HOH A 501 1.98 REMARK 500 O HOH B 526 O HOH B 617 2.00 REMARK 500 O HOH B 688 O HOH B 735 2.02 REMARK 500 O HOH A 686 O HOH A 739 2.05 REMARK 500 O HOH B 516 O HOH B 627 2.12 REMARK 500 OE1 GLN A 20 O HOH A 502 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 640 O HOH B 717 1455 1.96 REMARK 500 O HOH B 691 O HOH B 702 3744 2.16 REMARK 500 O HOH B 655 O HOH B 728 3744 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 17 CA - CB - SG ANGL. DEV. = 7.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 17 -156.03 -91.39 REMARK 500 SER A 71 -0.24 83.90 REMARK 500 ALA A 129 79.78 -150.59 REMARK 500 GLU A 145 59.78 -90.12 REMARK 500 GLU A 145 58.04 -90.12 REMARK 500 LYS A 232 73.38 -114.32 REMARK 500 CYS B 17 -160.11 -100.15 REMARK 500 CYS B 17 -158.11 -97.47 REMARK 500 LYS B 224 28.51 42.56 REMARK 500 ALA B 293 49.71 -154.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 403 DBREF 6RMT A 3 310 UNP P01024 CO3_HUMAN 996 1303 DBREF 6RMT B 3 310 UNP P01024 CO3_HUMAN 996 1303 SEQADV 6RMT MET A 1 UNP P01024 INITIATING METHIONINE SEQADV 6RMT LEU A 2 UNP P01024 EXPRESSION TAG SEQADV 6RMT MET B 1 UNP P01024 INITIATING METHIONINE SEQADV 6RMT LEU B 2 UNP P01024 EXPRESSION TAG SEQRES 1 A 310 MET LEU ASP ALA GLU ARG LEU LYS HIS LEU ILE VAL THR SEQRES 2 A 310 PRO SER GLY CYS GLY GLU GLN ASN MET ILE GLY MET THR SEQRES 3 A 310 PRO THR VAL ILE ALA VAL HIS TYR LEU ASP GLU THR GLU SEQRES 4 A 310 GLN TRP GLU LYS PHE GLY LEU GLU LYS ARG GLN GLY ALA SEQRES 5 A 310 LEU GLU LEU ILE LYS LYS GLY TYR THR GLN GLN LEU ALA SEQRES 6 A 310 PHE ARG GLN PRO SER SER ALA PHE ALA ALA PHE VAL LYS SEQRES 7 A 310 ARG ALA PRO SER THR TRP LEU THR ALA TYR VAL VAL LYS SEQRES 8 A 310 VAL PHE SER LEU ALA VAL ASN LEU ILE ALA ILE ASP SER SEQRES 9 A 310 GLN VAL LEU CYS GLY ALA VAL LYS TRP LEU ILE LEU GLU SEQRES 10 A 310 LYS GLN LYS PRO ASP GLY VAL PHE GLN GLU ASP ALA PRO SEQRES 11 A 310 VAL ILE HIS GLN GLU MET ILE GLY GLY LEU ARG ASN ASN SEQRES 12 A 310 ASN GLU LYS ASP MET ALA LEU THR ALA PHE VAL LEU ILE SEQRES 13 A 310 SER LEU GLN GLU ALA LYS ASP ILE CYS GLU GLU GLN VAL SEQRES 14 A 310 ASN SER LEU PRO GLY SER ILE THR LYS ALA GLY ASP PHE SEQRES 15 A 310 LEU GLU ALA ASN TYR MET ASN LEU GLN ARG SER TYR THR SEQRES 16 A 310 VAL ALA ILE ALA GLY TYR ALA LEU ALA GLN MET GLY ARG SEQRES 17 A 310 LEU LYS GLY PRO LEU LEU ASN LYS PHE LEU THR THR ALA SEQRES 18 A 310 LYS ASP LYS ASN ARG TRP GLU ASP PRO GLY LYS GLN LEU SEQRES 19 A 310 TYR ASN VAL GLU ALA THR SER TYR ALA LEU LEU ALA LEU SEQRES 20 A 310 LEU GLN LEU LYS ASP PHE ASP PHE VAL PRO PRO VAL VAL SEQRES 21 A 310 ARG TRP LEU ASN GLU GLN ARG TYR TYR GLY GLY GLY TYR SEQRES 22 A 310 GLY SER THR GLN ALA THR PHE MET VAL PHE GLN ALA LEU SEQRES 23 A 310 ALA GLN TYR GLN LYS ASP ALA PRO ASP HIS GLN GLU LEU SEQRES 24 A 310 ASN LEU ASP VAL SER LEU GLN LEU PRO SER ARG SEQRES 1 B 310 MET LEU ASP ALA GLU ARG LEU LYS HIS LEU ILE VAL THR SEQRES 2 B 310 PRO SER GLY CYS GLY GLU GLN ASN MET ILE GLY MET THR SEQRES 3 B 310 PRO THR VAL ILE ALA VAL HIS TYR LEU ASP GLU THR GLU SEQRES 4 B 310 GLN TRP GLU LYS PHE GLY LEU GLU LYS ARG GLN GLY ALA SEQRES 5 B 310 LEU GLU LEU ILE LYS LYS GLY TYR THR GLN GLN LEU ALA SEQRES 6 B 310 PHE ARG GLN PRO SER SER ALA PHE ALA ALA PHE VAL LYS SEQRES 7 B 310 ARG ALA PRO SER THR TRP LEU THR ALA TYR VAL VAL LYS SEQRES 8 B 310 VAL PHE SER LEU ALA VAL ASN LEU ILE ALA ILE ASP SER SEQRES 9 B 310 GLN VAL LEU CYS GLY ALA VAL LYS TRP LEU ILE LEU GLU SEQRES 10 B 310 LYS GLN LYS PRO ASP GLY VAL PHE GLN GLU ASP ALA PRO SEQRES 11 B 310 VAL ILE HIS GLN GLU MET ILE GLY GLY LEU ARG ASN ASN SEQRES 12 B 310 ASN GLU LYS ASP MET ALA LEU THR ALA PHE VAL LEU ILE SEQRES 13 B 310 SER LEU GLN GLU ALA LYS ASP ILE CYS GLU GLU GLN VAL SEQRES 14 B 310 ASN SER LEU PRO GLY SER ILE THR LYS ALA GLY ASP PHE SEQRES 15 B 310 LEU GLU ALA ASN TYR MET ASN LEU GLN ARG SER TYR THR SEQRES 16 B 310 VAL ALA ILE ALA GLY TYR ALA LEU ALA GLN MET GLY ARG SEQRES 17 B 310 LEU LYS GLY PRO LEU LEU ASN LYS PHE LEU THR THR ALA SEQRES 18 B 310 LYS ASP LYS ASN ARG TRP GLU ASP PRO GLY LYS GLN LEU SEQRES 19 B 310 TYR ASN VAL GLU ALA THR SER TYR ALA LEU LEU ALA LEU SEQRES 20 B 310 LEU GLN LEU LYS ASP PHE ASP PHE VAL PRO PRO VAL VAL SEQRES 21 B 310 ARG TRP LEU ASN GLU GLN ARG TYR TYR GLY GLY GLY TYR SEQRES 22 B 310 GLY SER THR GLN ALA THR PHE MET VAL PHE GLN ALA LEU SEQRES 23 B 310 ALA GLN TYR GLN LYS ASP ALA PRO ASP HIS GLN GLU LEU SEQRES 24 B 310 ASN LEU ASP VAL SER LEU GLN LEU PRO SER ARG HET CL A 401 1 HET CL B 401 1 HET CL B 402 1 HET CL B 403 1 HETNAM CL CHLORIDE ION FORMUL 3 CL 4(CL 1-) FORMUL 7 HOH *533(H2 O) HELIX 1 AA1 ASP A 3 ILE A 11 5 9 HELIX 2 AA2 GLU A 19 THR A 38 1 20 HELIX 3 AA3 GLN A 40 GLY A 45 1 6 HELIX 4 AA4 GLU A 47 LEU A 64 1 18 HELIX 5 AA5 ALA A 65 ARG A 67 5 3 HELIX 6 AA6 SER A 82 VAL A 97 1 16 HELIX 7 AA7 ASP A 103 GLN A 119 1 17 HELIX 8 AA8 HIS A 133 ARG A 141 5 9 HELIX 9 AA9 GLU A 145 GLU A 166 1 22 HELIX 10 AB1 SER A 171 TYR A 187 1 17 HELIX 11 AB2 MET A 188 LEU A 190 5 3 HELIX 12 AB3 ARG A 192 MET A 206 1 15 HELIX 13 AB4 LYS A 210 ALA A 221 1 12 HELIX 14 AB5 LYS A 232 LYS A 251 1 20 HELIX 15 AB6 PHE A 255 GLN A 266 1 12 HELIX 16 AB7 SER A 275 ALA A 293 1 19 HELIX 17 AB8 ASP B 3 ILE B 11 5 9 HELIX 18 AB9 GLU B 19 THR B 38 1 20 HELIX 19 AC1 GLN B 40 GLY B 45 1 6 HELIX 20 AC2 GLU B 47 ALA B 65 1 19 HELIX 21 AC3 SER B 82 ALA B 96 1 15 HELIX 22 AC4 VAL B 97 LEU B 99 5 3 HELIX 23 AC5 ASP B 103 GLN B 119 1 17 HELIX 24 AC6 HIS B 133 ASN B 142 5 10 HELIX 25 AC7 GLU B 145 GLU B 166 1 22 HELIX 26 AC8 SER B 171 TYR B 187 1 17 HELIX 27 AC9 MET B 188 LEU B 190 5 3 HELIX 28 AD1 ARG B 192 MET B 206 1 15 HELIX 29 AD2 LYS B 210 THR B 220 1 11 HELIX 30 AD3 LYS B 232 LEU B 250 1 19 HELIX 31 AD4 PHE B 255 GLN B 266 1 12 HELIX 32 AD5 SER B 275 ALA B 293 1 19 SSBOND 1 CYS A 17 CYS B 17 1555 1555 2.93 SSBOND 2 CYS A 108 CYS A 165 1555 1555 2.07 SSBOND 3 CYS B 108 CYS B 165 1555 1555 2.06 SITE 1 AC1 4 CYS A 17 GLY A 18 GLU A 19 GLN A 20 SITE 1 AC2 4 PHE A 76 VAL A 77 PHE B 76 VAL B 77 SITE 1 AC3 4 CYS B 17 GLY B 18 GLU B 19 GLN B 20 SITE 1 AC4 1 ARG B 49 CRYST1 54.624 59.896 175.488 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018307 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016696 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005698 0.00000